0000950170-24-034156.txt : 20240320 0000950170-24-034156.hdr.sgml : 20240320 20240320160704 ACCESSION NUMBER: 0000950170-24-034156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240318 FILED AS OF DATE: 20240320 DATE AS OF CHANGE: 20240320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaufmann Petra CENTRAL INDEX KEY: 0001905589 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41200 FILM NUMBER: 24767828 MAIL ADDRESS: STREET 1: C/O AFFINIA THERAPEUTICS INC. STREET 2: 43 FOUNDRY AVE, SUITE 120 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vigil Neuroscience, Inc. CENTRAL INDEX KEY: 0001827087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FORGE ROAD STREET 2: SUITE 700 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-254-4445 MAIL ADDRESS: STREET 1: 100 FORGE ROAD STREET 2: SUITE 700 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 ownership.xml 4 X0508 4 2024-03-18 0001827087 Vigil Neuroscience, Inc. VIGL 0001905589 Kaufmann Petra VIGIL NEUROSCIENCE, INC. 100 FORGE ROAD, SUITE 700 WATERTOWN MA 02472 false true false false Chief Medical Officer false Stock Option Grant (Right to Buy) 3.14 2024-03-18 4 A false 330000 0.00 A 2034-03-18 Common Stock 330000 330000 D This stock option award was issued subject to the terms of the Issuer's 2021 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on March 18, 2025 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter. /s/ Christopher Verni, Attorney-in-Fact 2024-03-20